- Home
- NSP vs CPRX Comparison
NSP vs CPRX Comparison
Compare NSP & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSP
- CPRX
- Stock Information
- Founded
- NSP 1986
- CPRX 2002
- Country
- NSP United States
- CPRX United States
- Employees
- NSP N/A
- CPRX N/A
- Industry
- NSP Professional Services
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- NSP Consumer Discretionary
- CPRX Health Care
- Exchange
- NSP Nasdaq
- CPRX Nasdaq
- Market Cap
- NSP 3.2B
- CPRX 2.8B
- IPO Year
- NSP 1997
- CPRX 2006
- Fundamental
- Price
- NSP $73.05
- CPRX $20.60
- Analyst Decision
- NSP Hold
- CPRX Strong Buy
- Analyst Count
- NSP 4
- CPRX 6
- Target Price
- NSP $95.67
- CPRX $30.50
- AVG Volume (30 Days)
- NSP 462.2K
- CPRX 1.0M
- Earning Date
- NSP 10-31-2024
- CPRX 11-06-2024
- Dividend Yield
- NSP 3.28%
- CPRX N/A
- EPS Growth
- NSP N/A
- CPRX 114.68
- EPS
- NSP 3.16
- CPRX 1.18
- Revenue
- NSP $6,547,871,000.00
- CPRX $460,482,000.00
- Revenue This Year
- NSP $2.24
- CPRX $21.99
- Revenue Next Year
- NSP $5.31
- CPRX $17.95
- P/E Ratio
- NSP $23.16
- CPRX $17.48
- Revenue Growth
- NSP 2.38
- CPRX 32.17
- 52 Week Low
- NSP $72.74
- CPRX $13.00
- 52 Week High
- NSP $119.41
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- NSP 34.66
- CPRX 39.71
- Support Level
- NSP $77.50
- CPRX $21.30
- Resistance Level
- NSP $81.54
- CPRX $24.27
- Average True Range (ATR)
- NSP 3.42
- CPRX 0.79
- MACD
- NSP -0.38
- CPRX -0.18
- Stochastic Oscillator
- NSP 2.35
- CPRX 4.18
About NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.